Dains K, Hitzemann B, Hitzemann R
Department of Psychiatry, SUNY at Stony Brook, New York, USA.
J Pharmacol Exp Ther. 1996 Dec;279(3):1430-8.
Compared with the neuroleptic nonresponsive (NNR) mouse line, the neuroleptic responsive (NR) line has a significantly higher number of striatal cholinergic neurons (Hitzemann et al., 1993). We now report additional information on this genetic association. At the fifth selected generation, a new selection of the NR and NNR lines differed 5-fold in their ED50 values (1 vs. 5 mg/kg) for haloperidol-induced catalepsy and 20% in the number of striatal cholinergic neurons (higher in the NR line). This association was further examined in 10 standard inbred mouse strains; eight of the strains had been crossed to form the heterogeneous stock from which the new NR and NNR lines were selected. In this panel, we detected no significant association between number of cholinergic neurons and haloperidol response. To examine the similarities and differences in the modes of inheritance for the two phenotypes, we formed a full Mendelian cross from the C57BL/6 (B6) and DBA/2 (D2) mouse strains. The B6 and D2 strains differ 9-fold in their haloperidol ED50 values (3.9 vs. 0.4 mg/kg) and more than 30% in the number of cholinergic neurons (higher in the D2 strain). Haloperidol-induced catalepsy was described by a simple additive genetic model; the narrow sense heritability was 0.60. In contrast, for the number of cholinergic neurons, the B6 genotype was dominant and heterosis was detected in the F1 cross. Despite the differences in heritability, among B6D2 F2 individuals, increasing haloperidol sensitivity was associated with increasing numbers of striatal cholinergic neurons. The BXD recombinant inbred series (25 strains) showed a 16-fold range of variation in the haloperidol ED50 and a greater than 50% variation in the number of striatal cholinergic neurons. However, we detected no significant association between haloperidol response and number of cholinergic neurons. Overall, the data suggest that the genetic association between the phenotypes is modest, complex and detectable only with some genetic strategies.
与抗精神病药物无反应(NNR)小鼠品系相比,抗精神病药物有反应(NR)品系的纹状体胆碱能神经元数量显著更多(希茨曼等人,1993年)。我们现在报告关于这种基因关联的更多信息。在第五代选择时,新选择的NR和NNR品系在氟哌啶醇诱导的僵住症的半数有效剂量(ED50)值(1对5毫克/千克)上相差5倍,在纹状体胆碱能神经元数量上相差20%(NR品系更高)。在10个标准近交小鼠品系中进一步研究了这种关联;其中8个品系已杂交形成了用于选择新的NR和NNR品系的异质群体。在这个群体中,我们未检测到胆碱能神经元数量与氟哌啶醇反应之间存在显著关联。为了研究这两种表型遗传模式的异同,我们从C57BL/6(B6)和DBA/2(D2)小鼠品系进行了完整的孟德尔杂交。B6和D2品系在氟哌啶醇ED50值上相差9倍(3.9对0.4毫克/千克),在胆碱能神经元数量上相差超过30%(D2品系更高)。氟哌啶醇诱导的僵住症由一个简单的加性遗传模型描述;狭义遗传力为0.60。相比之下,对于胆碱能神经元数量,B6基因型是显性的,并且在F1杂交中检测到杂种优势。尽管遗传力存在差异,但在B6D2 F2个体中,氟哌啶醇敏感性增加与纹状体胆碱能神经元数量增加相关。BXD重组近交系(25个品系)显示氟哌啶醇ED50有16倍的变化范围,纹状体胆碱能神经元数量有超过50%的变化。然而,我们未检测到氟哌啶醇反应与胆碱能神经元数量之间存在显著关联。总体而言,数据表明这些表型之间的基因关联程度适中、复杂,并且仅通过某些遗传策略才能检测到。